GTx

GTx, Inc. is a biopharmaceutical company based in Memphis, Tennessee. The company employs 173 people and generates revenue exceeding $10,000. GTx focuses its efforts on the research, development, and marketing of small molecule drugs. GTx specializes in developing therapeutics for a range of serious medical conditions, with a particular emphasis on cancer treatments. Their portfolio includes medications aimed at addressing breast and prostate cancer. GTx is committed to advancing the field of medicine through the development of innovative and effective small molecule therapies. For more information about GTx, Inc. and their products, please visit their website at gtxinc.com.